- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: buserelin
Total 302 results
-
Dana-Farber Cancer InstituteCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
West China HospitalNot yet recruitingProstate CancerChina
-
National Cancer Center, JapanPfizer; Korean Cancer Study GroupActive, not recruitingBreast NeoplasmsKorea, Republic of, Singapore, Japan, Taiwan
-
Novartis PharmaceuticalsSuspendedEarly Breast CancerAustralia
-
Washington University School of MedicinePfizerActive, not recruitingBreast NeoplasmsUnited States
-
SanofiTerminatedBreast CancerUnited States, Russian Federation, Italy, Australia, Belgium, France, Japan, Ukraine, Netherlands, Argentina, Canada, Portugal, Spain, Austria, Brazil, Bulgaria, Chile, China, Czechia, Finland, Georgia, Germany, Hungary, Korea, Republic... and more
-
University of Sao PauloTerminated
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Haukeland University HospitalPfizer; AstraZeneca; Helse VestActive, not recruitingBreast CancerNorway
-
Rana McKay, MDUniversity of California, San Diego; AstraZenecaRecruitingProstate Cancer | BRCA1 Mutation | BRCA2 Mutation | Prostatic Adenocarcinoma | High-Risk CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Taiwan, Canada, Germany, Argentina, Israel, Korea, Republic of, Denmark, France, India, Chile, Netherlands, Singapore, Japan, Mexico
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more
-
Cancer Institute and Hospital, Chinese Academy...Novartis PharmaceuticalsUnknownMetastatic Breast CancerChina
-
University of California, San FranciscoNational Cancer Institute (NCI)TerminatedProstate AdenocarcinomaUnited States
-
Women's Hospital School Of Medicine Zhejiang UniversityNot yet recruitingSubmucous Leiomyoma of UterusChina
-
University of Colorado, DenverRecruitingHypertension | Prostate Cancer | Autonomic Dysfunction | Androgen Deprivation Therapy | Renal DiseaseUnited States
-
University of Kansas Medical CenterCompletedProstate CancerUnited States
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruiting
-
Institute of Cancer Research, United KingdomScottish Cancer Therapy Network; Cancer Research Campaign Clinical Trials Centre and other collaboratorsCompleted
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
National Institute of Diabetes and Digestive and...Merck Sharp & Dohme LLC; Medtronic; Sanofi-Synthelabo; Diagnostic Ultrasound; Uro...Terminated
-
M.D. Anderson Cancer CenterPfizerCompletedProstate CancerUnited States
-
Korea University Anam HospitalGL Pharm Tech CorporationCompletedBenign Prostatic Hyperplasia (BPH)Korea, Republic of
-
Medical College of WisconsinActive, not recruiting
-
German Breast GroupPfizerCompletedMale Breast CancerGermany
-
Washington University School of MedicinePfizerCompletedBreast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of BreastUnited States
-
VA Office of Research and DevelopmentRecruitingRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Oligometastasis | Oligorecurrence | De Novo Prostate CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States, South Africa
-
Mayo ClinicNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage III Prostate Cancer | Stage IV Prostate CancerUnited States
-
Fondazione Sandro PitiglianiNovartisActive, not recruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruiting
-
Spanish Breast Cancer Research GroupPfizerCompleted
-
Blokhin's Russian Cancer Research CenterRecruitingBreast Cancer | Neoadjuvant Endocrine TherapyRussian Federation
-
Washington University School of MedicinePfizer; Rising Tide FoundationTerminatedBreast Cancer | Breast Carcinoma | Cancer of BreastUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive TumorChina
-
Embera NeuroTherapeutics, Inc.National Institute on Drug Abuse (NIDA)CompletedCocaine Use DisorderUnited States
-
Japan Breast Cancer Research GroupChugai PharmaceuticalCompletedMetastatic Breast CancerJapan
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
City of Hope Medical CenterActive, not recruitingProstate AdenocarcinomaUnited States
-
Austrian Breast & Colorectal Cancer Study GroupAstraZenecaCompletedRandomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive PatientsEarly-stage Breast Cancer
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Spanish Breast Cancer Research GroupEli Lilly and CompanyActive, not recruiting
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States, Canada, Puerto Rico
-
National Institute of Oncology, HungaryNot yet recruiting
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
M.D. Anderson Cancer CenterActive, not recruitingProstate Adenocarcinoma | Recurrent Prostate CarcinomaUnited States
-
Palleos Healthcare GmbHRoche Pharma AG; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUPCompleted
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | HER2-Positive Breast Carcinoma | Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostatic Adenocarcinoma | Castration Levels of TestosteroneUnited States, Switzerland, Mexico, Chile, Colombia